Entering into strategic alliances and in-licensing pipeline products has become an increasingly important activity for pharmaceutical and biotechnology companies. The industry is challenged by the pressure to regularly launch new drugs. This challenge is increasingly met by partnering with other companies. Alliance databases can be used to assess competitors' activities, search for possible in-licensing candidates, and to benchmark deals terms.
PharmaDeals®. PharmaVentures Ltd, Magdalen Centre, Oxford Science Park, Oxford OX4 4GA, U.K. Phone: +441865-784-177, Fax: +44-1865-784-178. E-mail: [email protected] pharmaventures.com. URL: http://www.pharmaventures. com. North American contact: Financial District Center, 425 Market Street, Suite 2200, San Francisco, CA 94105, U.S.A. Phone: +1 415-512-6488, Fax: +1 415-397-6309.
PharmaVentures has several databases useful for assessing existing agreements in the pharmaceutical industry and also for looking for new opportunities. The PharmaDeals Agreements module has details on over 20,000 deals, and since late 2003, includes filed contracts where available. The Pharma-Deals Opportunities database has nearly 900 licensing and partnering opportunities that have been submitted to Phar-maVentures from companies with products available for licensing. Two other modules are the PharmaDeals Review, a monthly review of trends and developments in pharmaceutical deal making, and PharmaDeals Survey, a benchmarking study that tracks successes and failures in the pharmaceutical deal-making arena. Access is available through an Internet subscription.
Recombinant Capital. 2033 N Main Street, Suite 1050, Walnut Creek, CA 94596, U.S.A. Phone: +1 925-952-3870, Fax: +1 925-952-3871. E-mail: [email protected]. URL: http://www. recap.com. Recombinant Capital is a consulting firm that focuses on biotechnology alliances. Their Biotech Alliance Database collects data on alliances of biotechnology companies with major pharmaceutical companies, universities, and other biotechnology companies. The firm also analyzes publicly filed contracts from the SEC. The searchable database covers over 20,000 biotechnology alliances and dates back to 1978. Recombinant Capital also has press releases, a Valuations Database with the financing histories of over 600 biotechnology companies, and a Clinical Trials Progress Database that tracks the progress of over 1,600 clinical trials of drugs in the biotechnology space. Recombinant Capital also has a premium database, rDNA.com, which in addition to the alliance, valuation, and clinical trials databases, includes historical sales data for 55 biotech products with graphs and detailed notes. An employment agreements database is also available, containing over 2000 unedited biotechnology executive employment agreements. Access is available through an Internet subscription.
Pharmaceutical Agreement News. Espicom Business Intelligence, Lincoln House, City Fields Business Park, City
Fields Way, Chichester, West Sussex, P020 2FS, U.K. Phone: +44-1243-533322, Fax: +44-1243-533418. North American contact: 116 Village Boulevard, Princeton Forrestal Village, Princeton, NJ 08540, U.S.A. Phone: +1 609-951-2227. Fax: +1 609-734-7428. URL: http://www.espicom.com. Pharmaceutical Agreement News (PAN) is an alliance news source that covers new, updated, and discontinued alliances and agreements in the industry. The newsletter is produced bimonthly and is available in print, e-mail, and Web formats.
Windhover Information Inc., 10 Hoyt St. Norwalk, CT 06851, U.S.A. Phone: +1 203-838-4401 ext. 232. Fax: +1 203-838-3214. E-mail: [email protected]. URL: http://www.windhover. com. Windhover provides information, commentary, and analysis on strategy, deal making and trends in the pharmaceutical and healthcare markets via a collection of databases called Strategic Intelligence Systems (SIS). The Strategic Transactions database is a compilation of deal activity from both public and private companies within the pharmaceutical, biotechnology, medical device, and diagnostic sectors. SIS databases cover alliances, financing, and M&A activity. Each database is updated bi-monthly and contains data on over 15,000 deals from 1991 to present. Alliance contracts that have been submitted to SEC are also available. Users can also search the archives of Windhover's journals In Vivo, Start-Up, and In Vivo Europe Rx. Access is available through an Internet subscription. In 2005, Windhover will be adding a new publication, The RPM Report: Regulation, Policy, and Market Access, which will cover government regulation and reimbursement.
Was this article helpful?